These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 37830609)

  • 21. Saponins as Natural Adjuvant for Antisense Morpholino Oligonucleotides Delivery In Vitro and in mdx Mice.
    Wang M; Wu B; Shah SN; Lu P; Lu Q
    Mol Ther Nucleic Acids; 2018 Jun; 11():192-202. PubMed ID: 29858054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Understanding Antisense Oligonucleotide Efficiency in Inhibiting Prokaryotic Gene Expression.
    Story S; Bhaduri S; Ganguly S; Dakarapu R; Wicks SL; Bhadra J; Kwange S; Arya DP
    ACS Infect Dis; 2024 Mar; 10(3):971-987. PubMed ID: 38385613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peptide-conjugated antimiRs improve myotonic dystrophy type 1 phenotypes by promoting endogenous MBNL1 expression.
    González-Martínez I; Cerro-Herreros E; Moreno N; García-Rey A; Espinosa-Espinosa J; Carrascosa-Sàez M; Piqueras-Losilla D; Arzumanov A; Seoane-Miraz D; Jad Y; Raz R; Wood MJ; Varela MA; Llamusí B; Artero R
    Mol Ther Nucleic Acids; 2023 Dec; 34():102024. PubMed ID: 37744174
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Convergent synthesis of phosphorodiamidate morpholino oligonucleotides (PMOs) by the H-phosphonate approach.
    Tsurusaki T; Sato K; Imai H; Hirai K; Takahashi D; Wada T
    Sci Rep; 2023 Aug; 13(1):12576. PubMed ID: 37537221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparative analysis of peptide-delivered antisense antibiotics using diverse nucleotide mimics.
    Ghosh C; Popella L; Dhamodharan V; Jung J; Dietzsch J; Barquist L; Höbartner C; Vogel J
    RNA; 2024 May; 30(6):624-643. PubMed ID: 38413166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generalizable anchor aptamer strategy for loading nucleic acid therapeutics on exosomes.
    Han G; Zhang Y; Zhong L; Wang B; Qiu S; Song J; Lin C; Zou F; Wu J; Yu H; Liang C; Wen K; Seow Y; Yin H
    EMBO Mol Med; 2024 Apr; 16(4):1027-1045. PubMed ID: 38448545
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peptide-Conjugated Phosphorodiamidate Morpholino Oligomers for In Situ Live-Cell Molecular Imaging of Dengue Virus Replication.
    Victorio CBL; Novera W; Tham JY; Watanabe S; Vasudevan SG; Chacko AM
    Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33291644
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemistry of Peptide-Oligonucleotide Conjugates: A Review.
    Klabenkova K; Fokina A; Stetsenko D
    Molecules; 2021 Sep; 26(17):. PubMed ID: 34500849
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sequencing of Morpholino Antisense Oligonucleotides Using Electron Capture Dissociation Mass Spectrometry.
    Karasawa K; Duchoslav E; Burton L; Kawakami J; Baba T
    Anal Chem; 2023 Nov; 95(44):16352-16358. PubMed ID: 37871344
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-viral delivery of nucleic acid for treatment of rare diseases of the muscle.
    Rao D; Ganguli M
    J Biosci; 2024; 49():. PubMed ID: 38383972
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of DNA transcription: The future of ASO therapeutics?
    Khvorova A
    Cell; 2022 Jun; 185(12):2011-2013. PubMed ID: 35688130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis of Self Permeable Antisense PMO Using C5-Guanidino-Functionalized Pyrimidines at the 5'-End Enables Sox2 Downregulation in Triple Negative Breast Cancer Cells.
    Das A; Gupta S; Shaw P; Sinha S
    Mol Pharm; 2024 Mar; 21(3):1256-1271. PubMed ID: 38324380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cell penetrating peptides: overview and applications to the delivery of oligonucleotides.
    Said Hassane F; Saleh AF; Abes R; Gait MJ; Lebleu B
    Cell Mol Life Sci; 2010 Mar; 67(5):715-26. PubMed ID: 19898741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Absorption, Distribution, Metabolism, and Excretion of US Food and Drug Administration-Approved Antisense Oligonucleotide Drugs.
    Migliorati JM; Liu S; Liu A; Gogate A; Nair S; Bahal R; Rasmussen TP; Manautou JE; Zhong XB
    Drug Metab Dispos; 2022 Jun; 50(6):888-897. PubMed ID: 35221287
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Use of Tricyclo-DNA Oligomers for the Treatment of Genetic Disorders.
    Aupy P; Echevarría L; Relizani K; Goyenvalle A
    Biomedicines; 2017 Dec; 6(1):. PubMed ID: 29271929
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell-Penetrating Peptides for Antiviral Drug Development.
    Delcroix M; Riley LW
    Pharmaceuticals (Basel); 2010 Mar; 3(3):448-470. PubMed ID: 27713263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nature-inspired peptide of MtDef4 C-terminus tail enables protein delivery in mammalian cells.
    Lifshits LA; Breuer Y; Sova M; Gupta S; Kadosh D; Weinberg E; Hayouka Z; Bar DZ; Gal M
    Sci Rep; 2024 Feb; 14(1):4604. PubMed ID: 38409451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of Chemically Modified Nucleic Acid Analogues for Splice Switching Application.
    Le BT; Chen S; Veedu RN
    ACS Omega; 2023 Dec; 8(51):48650-48661. PubMed ID: 38162739
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intracellular Delivery of Antisense Oligonucleotides by Tri-Branched Cyclic Disulfide Units.
    Lyu F; Hakariya H; Hiraoka H; Li Z; Matsubara N; Soo Y; Hashiya F; Abe N; Shu Z; Nakamoto K; Kimura Y; Abe H
    ChemMedChem; 2024 Jul; ():e202400472. PubMed ID: 38957922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. General and Specific Cytotoxicity of Chimeric Antisense Oligonucleotides in Bacterial Cells and Human Cell Lines.
    Popova KB; Penchovsky R
    Antibiotics (Basel); 2024 Jan; 13(2):. PubMed ID: 38391508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.